Macquarie Group LTD Pacira Bio Sciences, Inc. Transaction History

Macquarie Group LTD

$85.1 Billion
Q2 2024

A detailed history of Macquarie Group LTD transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 1,567,013 shares of PCRX stock, worth $22.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,567,013

Previous 1,561,039 0.38%

Holding current value

$22.8 Million

Previous $45.6 Million 1.71%

% of portfolio

0.05%

Previous 0.05%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$25.5 - $31.51 $152,337 - $188,240	5,974 Added 0.38%	1,567,013 $44.8 Million
Q1 2024 May 14, 2024	BUY	$27.7 - $35.48 $4.9 Million - $6.28 Million	176,876 Added 12.78%	1,561,039 $45.6 Million
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $7.31 Million - $9.53 Million	-277,750 Reduced 16.71%	1,384,163 $46.7 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $28.7 Million - $37.5 Million	935,255 Added 128.71%	1,661,913 $51 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $18.4 Million - $24.2 Million	-508,840 Reduced 41.19%	726,658 $29.1 Million
Q1 2023 May 15, 2023	SELL	$35.53 - $43.38 $28.5 Million - $34.8 Million	-801,551 Reduced 39.35%	1,235,498 $50.4 Million
Q4 2022 Feb 21, 2023	SELL	$38.19 - $57.45 $34.2 Million - $51.5 Million	-896,749 Reduced 30.57%	2,037,049 $78.7 Million
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $32.3 Million - $37.1 Million	-630,109 Reduced 17.68%	2,933,798 $156 Million
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $25.6 Million - $40.6 Million	-497,905 Reduced 12.26%	3,563,907 $208 Million
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $17.2 Million - $21.9 Million	286,509 Added 7.59%	4,061,812 $310 Million
Q4 2021 Feb 11, 2022	BUY	$47.97 - $62.21 $4.3 Million - $5.57 Million	89,549 Added 2.43%	3,775,303 $227 Million
Q3 2021 Nov 12, 2021	SELL	$54.64 - $61.3 $1.61 Million - $1.81 Million	-29,510 Reduced 0.79%	3,685,754 $206 Million
Q2 2021 Aug 13, 2021	BUY	$59.18 - $69.99 $25 Million - $29.6 Million	423,133 Added 12.85%	3,715,264 $225 Million
Q1 2021 May 14, 2021	BUY	$59.31 - $78.82 $31.9 Million - $42.4 Million	538,103 Added 19.54%	3,292,131 $231 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $15.5 Million - $20.4 Million	307,942 Added 12.59%	2,754,028 $165 Million
Q3 2020 Nov 13, 2020	BUY	$51.97 - $63.0 $21.8 Million - $26.5 Million	420,314 Added 20.75%	2,446,086 $147 Million
Q2 2020 Aug 11, 2020	BUY	$30.8 - $52.47 $9.81 Million - $16.7 Million	318,464 Added 18.65%	2,025,772 $106 Million
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $10.4 Million - $18.5 Million	-364,866 Reduced 17.61%	1,707,308 $57.2 Million
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $10 Million - $12.9 Million	276,319 Added 15.39%	2,072,174 $93.9 Million
Q3 2019 Nov 14, 2019	SELL	$35.66 - $44.99 $4.08 Million - $5.15 Million	-114,439 Reduced 5.99%	1,795,855 $68.4 Million
Q2 2019 Aug 14, 2019	BUY	$36.57 - $47.97 $3.82 Million - $5.01 Million	104,428 Added 5.78%	1,910,294 $83.1 Million
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $12.1 Million - $13.9 Million	-330,466 Reduced 15.47%	1,805,866 $68.7 Million
Q4 2018 Feb 15, 2019	SELL	$41.31 - $52.16 $13.1 Million - $16.6 Million	-317,556 Reduced 12.94%	2,136,332 $91.9 Million
Q3 2018 Nov 15, 2018	BUY	$32.85 - $52.0 $4.36 Million - $6.9 Million	132,763 Added 5.72%	2,453,888 $121 Million
Q2 2018 Aug 14, 2018	BUY	$27.5 - $39.8 $21.1 Million - $30.6 Million	768,011 Added 49.45%	2,321,125 $74.4 Million
Q1 2018 May 11, 2018	BUY	$29.98 - $46.35 $8.6 Million - $13.3 Million	286,700 Added 22.64%	1,553,114 $48.4 Million
Q4 2017 Feb 15, 2018	BUY	$31.85 - $46.95 $3.56 Million - $5.25 Million	111,869 Added 9.69%	1,266,414 $57.8 Million
Q3 2017 Nov 08, 2017	BUY	$35.7 - $39.5 $41.2 Million - $45.6 Million	1,154,545	1,154,545 $43.4 Million

Others Institutions Holding PCRX

# of Institutions

301

Shares Held

51.5M

Call Options Held

378K

Put Options Held

1.53M

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $666M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Account

Macquarie Group LTD Pacira Bio Sciences, Inc. Transaction History